SANOFI.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Stats
Dagens volum	14 173.00
Gjennomsnittsvolum	18 615.00
Markedsverdi	190.63B
EPS	INR0 ( 2024-02-23 )
Neste inntjeningsdato	( INR0 ) 2024-05-10
Last Dividend	INR183.00 ( 2023-04-28 )
Next Dividend	INR0 ( N/A )
P/E	31.66
ATR14	INR5.49 (0.07%)

Volum Korrelasjon

Lang: 0.11 (neutral)

Kort: 0.38 (neutral)

Signal:(50.56) Neutral

Sanofi India Limited Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Sanofi India Limited Korrelasjon - Valuta/Råvare

-0.41
( neutral )

0.05
( neutral )

-0.22
( neutral )

-0.64
( weak negative )

-0.73
( moderate negative )

0.47
( neutral )

Sanofi India Limited Økonomi

Annual	2023
Omsetning:	INR28.51B
Bruttogevinst:	INR12.40B (43.49 %)
EPS:	INR261.78

FY	2023
Omsetning:	INR28.51B
Bruttogevinst:	INR12.40B (43.49 %)
EPS:	INR261.78

FY	2022
Omsetning:	INR27.70B
Bruttogevinst:	INR15.81B (57.06 %)
EPS:	INR269.47

FY	2021
Omsetning:	INR29.57B
Bruttogevinst:	INR16.50B (55.80 %)
EPS:	INR410.06

Financial Reports:

No articles found.

Sanofi India Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR193.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR183.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Sanofi India Limited Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.09 - Stable (18.29%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR13.50	2003-05-30
Last Dividend	INR183.00	2023-04-28
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	39	--
Total Paid Out	INR1 983.50	--
Avg. Dividend % Per Year	2.98%	--
Score	4.36	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.09
Div. Directional Score	7.59	--

Next Divdend (Est)
(2024-10-07)

INR189.96 Estimate 3.64 %

Dividend Stability

0.29 Very Poor

Dividend Score

4.36

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR71.00	1.47%
2019	INR66.00	1.04%
2020	INR486.00	6.93%
2021	INR240.00	2.90%
2022	INR502.00	6.45%
2023	INR183.00	3.14%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SUTLEJTEX.NS	Dividend Junior	2023-08-18	Annually	18	1.03%
NDRAUTO.NS	Dividend Junior	2023-07-12	Annually	4	0.59%
ICICIGI.NS	Dividend Junior	2023-06-12	Annually	8	0.36%
CENTENKA.NS	Dividend Junior	2023-08-11	Annually	22	1.85%
RUBYMILLS.NS	Dividend Junior	2023-09-20	Annually	23	0.96%
LINCOLN.NS	Dividend Junior	2023-09-15	Annually	9	0.32%
GEECEE.NS	Dividend Junior	2023-09-08	Sporadic	18	0.97%
ARIHANTCAP.NS	Dividend Junior	2023-07-28	Annually	4	0.39%
TEXINFRA.NS	Dividend Junior	2023-09-18	Annually	20	0.18%
OPTIEMUS.NS	Dividend Junior	2023-06-07	Insufficient data to determine frequency	2	0.16%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.211	1.500	5.77	8.66	[0 - 0.5]
returnOnAssetsTTM	0.352	1.200	10.00	10.00	[0 - 0.3]
returnOnEquityTTM	0.645	1.500	3.95	5.92	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.916	0.800	5.42	4.34	[1 - 3]
quickRatioTTM	0.860	0.800	9.65	7.72	[0.8 - 2.5]
cashRatioTTM	0.624	1.500	7.64	10.00	[0.2 - 2]
debtRatioTTM	0.0111	-1.500	9.82	-10.00	[0 - 0.6]
interestCoverageTTM	480.82	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	25.53	2.00	1.490	2.98	[0 - 30]
freeCashFlowPerShareTTM	25.53	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0187	-1.500	9.93	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.543	1.000	4.28	4.28	[0.2 - 0.8]
operatingProfitMarginTTM	0.287	1.000	6.27	6.27	[0.1 - 0.6]
cashFlowToDebtRatioTTM	3.09	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.663	0.800	2.25	1.799	[0.5 - 2]
Total Score				11.10

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	31.88	1.000	6.88	0	[1 - 100]
returnOnEquityTTM	0.645	2.50	6.11	5.92	[0.1 - 1.5]
freeCashFlowPerShareTTM	25.53	2.00	1.490	10.00	[0 - 30]
dividendYielPercentageTTM	0.599	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	25.53	2.00	1.490	2.98	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.12	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0206	1.000	-1.984	0	[0.1 - 0.5]
Total Score				4.09

Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.